Contribute Try STAT+ Today

Exclusive

Most Read

yellow background iv bag

Exclusive By Damian Garde

Sesen Bio trial of cancer drug marked by misconduct and worrisome side effects, documents show

Moderna sign

Exclusive By Damian Garde

Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine

Aubrey de Grey

Exclusive By Megan Molteni

Anti-aging foundation’s CEO left amid an investigation of co-founder Aubrey de Grey

Pascal Soriot 2019

Exclusive By Adam Feuerstein

Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Dr. Neel Shah

Exclusive By Erin Brodwin

In a new role at health tech startup Maven, Neel Shah wants to make sure pregnant people aren’t ‘lost’

3/1 Trump

Exclusive By Rachel Cohrs

The Trump administration quietly spent billions in hospital funds on Operation Warp Speed

Biogen Aduhelm illo

Exclusive By Adam Feuerstein, Matthew Herper and Damian Garde

Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug

All Coverage

funding illo

Exclusive By Erin Brodwin

Cityblock Health raises another mega-round of funding, tipping its valuation over $5 billion

BIO rebuild

Exclusive By Nicholas Florko

‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby

advertisement

Exclusive By Olivia Goldhill

Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist

one hundred dollar bills

Exclusive By Kate Sheridan

Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms

Leen Kawas-Athira

Exclusive By Olivia Goldhill

Athira cited altered studies in $15 million NIH grant application, creating legal risk

Virus Outbreak Kids Heart Inflammation

Exclusive By Nicholas Florko

FDA, under pressure, plans ‘sprint’ to accelerate review of Pfizer’s Covid-19 vaccine for full approval

insulin biosimilar

Exclusive By Nicholas Florko, Ed Silverman, Rachel Cohrs and Damian Garde

FDA’s expansive Alzheimer’s drug approval surprised even top agency officials

Gustave Perna

Exclusive By Nicholas Florko

Perna set to retire from Warp Speed later this summer

Leen Kawas WSU

Exclusive By Olivia Goldhill

Athira Pharma CEO placed on leave amid allegations of altered images in her research papers

Covid swab UK

Exclusive By Kathleen McLaughlin

FDA accuses company of distributing unapproved Covid test and using falsified data

Erich Huang

Exclusive By Erin Brodwin

Onduo’s new exec on Google’s data skills, real-world evidence, and moving the needle on outcomes

digital diabetes care

Exclusive By Erin Brodwin

Carbon Health dives into digital diabetes care with virtual clinic acquisition

King Shkreli

Exclusive By Adam Feuerstein and Damian Garde

Martin Shkreli’s longtime friend wants to undo his 4,000% price hike. But first he’ll have to finally oust the ‘pharma bro’

Exclusive By Olivia Goldhill and Rachel Cohrs

Boxed in: How a single Pfizer decision complicated the Covid vaccine rollout while boosting profits

RNA illustration

Exclusive By Megan Molteni and Katie Palmer

From two unusual organ donations, scientists garner a unique trove of single-cell genetic data

Kelvin Droegemeier

Exclusive By Nicholas Florko

Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews

Pelosi - October 2019

Exclusive By Nicholas Florko

Key House Democrats’ push for a ‘bipartisan’ drug pricing bill could doom Pelosi’s signature legislation

director gen tedros

Exclusive By Helen Branswell

WHO’s Tedros plans to seek reelection, setting up referendum on his leadership

colorful brain MRI

Exclusive By Megan Molteni

Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims

paperwork mountain

Exclusive By Erin Brodwin

With $12 million in new funding, data-syncing platform Seqster takes aim at health records

John Cornyn

Exclusive By Rachel Cohrs and Lev Facher

Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver

1/21 executive order

Exclusive By Nicholas Florko

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile

Prescription meds and money

Exclusive By Nicholas Florko

PhRMA’s new message to Washington: Don’t take us for granted

Michelle Carnahan

Exclusive By Erin Brodwin

Digital pharmacy startup Thirty Madison taps former Lilly exec as president

Seema V.

Exclusive By Erin Brodwin

Former Medicare leader Seema Verma joins board of health tech firm Lumeris